Arthroscopic shoulder stabilization with the bioabsorbable Suretac device (
Acufex Microsurgical, Mansfield, MA) offers some technical advantages compa
red with other approaches. However,: in 4 patients (3 men, 1 woman; between
20 and 35 years of age) with 3 SLAP lesions grades 2 and 1 post-traumatic
anterior shoulder instability, breakage and early loosening of the Suretac
device was observed. All patients complained about shoulder pain and loss o
f active and passive motion. The arthroscopic examination revealed a massiv
e synovitis without positive cultures. Loose fragments of the Suretac devic
e spread in the joint cavity and induced a foreign-body reaction. Histologi
cally, there was a massive infiltration of phagocytic cells (histiocytes, m
ultinucleated giant cells) and birefringent polymeric particles surrounded
by:or within histiocytes and multinucleated giant cells. All patients under
went arthroscopic synovectomy. Because of instability, 2 of them required r
estabilization. which was performed with suture anchors (Fastak [Arthrex, N
aples, FL], Mitek [Mitek Division, Ethicon, Norder-stedt, Germany]). Postop
eratively all patients were:pain; free, progressing to full active and pass
ive range of motion. Our patients suffered from a mechanical failure rather
than from a predisposition to exaggerated inflammatory response. According
to this observation, the Suretac device seems to be prone to early failure
in patients with SLAP lesions because of its biodegradability.